Dynavax Technologies
DVAX
#5491
Rank
โ‚น115.75 B
Marketcap
โ‚น985.74
Share price
-0.09%
Change (1 day)
-9.72%
Change (1 year)

Dynavax Technologies (DVAX) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น48.04 Billion

According to Dynavax Technologies 's latest financial reports the company has โ‚น48.04 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Dynavax Technologies - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น51.19 B-1.14%
2023-12-31$โ‚น51.78 B7.71%
2022-12-31$โ‚น48.07 B190.48%
2021-12-31$โ‚น16.55 B285.6%
2020-12-31$โ‚น4.29 B626.1%
2019-12-31$โ‚น0.59 B-86.59%
2018-12-31$โ‚น4.40 B-65.39%
2017-12-31$โ‚น12.74 B110.2%
2016-12-31$โ‚น6.06 B-51.24%
2015-12-31$โ‚น12.43 B95.22%
2014-12-31$โ‚น6.36 B-44.67%
2013-12-31$โ‚น11.50 B83.06%
2012-12-31$โ‚น6.28 B18.99%
2011-12-31$โ‚น5.28 B126.27%
2010-12-31$โ‚น2.33 B689.29%
2009-12-31$โ‚น0.29 B-61.9%
2008-12-31$โ‚น0.77 B-49.43%
2007-12-31$โ‚น1.53 B-56.15%
2006-12-31$โ‚น3.50 B4.65%
2005-12-31$โ‚น3.34 B29.05%
2004-12-31$โ‚น2.59 B-199.57%
2003-12-31$-โ‚น2.61 Billion-3.66%
2002-12-31$-โ‚น2.71 Billion62.78%
2001-12-31$-โ‚น1.67 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-โ‚น25.27 Billion-152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น1.637 T 3,308.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น4.668 T 9,617.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น1.929 T 3,916.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น4.134 T 8,506.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚น1.904 T 3,864.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น8.373 T 17,329.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น652.42 B 1,258.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚น865.13 B 1,700.85%๐Ÿ‡บ๐Ÿ‡ธ USA